Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001571049-15-005234
Filing Date
2015-06-23
Accepted
2015-06-22 18:00:56
Documents
5
Effectiveness Date
2015-06-23

Document Format Files

Seq Description Document Type Size
1 FORM S-8 t1501447_s8.htm S-8 72709
2 EXHIBIT 5.1 t1501447_ex5-1.htm EX-5.1 11205
3 EXHIBIT 10.2 t1501447_ex10-2.htm EX-10.2 76053
4 EXHIBIT 23.2 t1501447_ex23-2.htm EX-23.2 1229
5 GRAPHIC logoex5-1.jpg GRAPHIC 4951
  Complete submission text file 0001571049-15-005234.txt   169288
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-205153 | Film No.: 15945629
SIC: 2834 Pharmaceutical Preparations